Delayed allergic reactions following intramuscular L-asparaginase.
L-asparaginase, a highly effective anti-leukemic enzyme preparation is now frequently being administered intramuscularly in order to decrease the incidence of severe sensitivity reactions. Although the occurrence of immediate hypersensitivity reactions and anaphylaxis has been diminished through this technique, we report three patients who developed delayed allergic reactions occurring hours after drug administration. This suggests that patients receiving L-asparaginase intramuscularly merit prolonged observation periods beyond the usual one half to one hour.
D000293:Adolescent; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D002648:Child; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D007273:Injections, Intramuscular; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male
D001215:Asparaginase